FDA Approved: ANGELIQ — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved ANGELIQ—Supplemental Application for the Bayer HealthCare Pharmaceuticals Inc. product. The approval concerns the drospirenone and estradiol combin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Osteoporosis

Drugs mentioned

• ANGELIQ (DROSPIRENONE AND ESTRADIOL)

Snippet

SUPPL AP for ANGELIQ (DROSPIRENONE AND ESTRADIOL)